Personal tools

Coexpression cluster:C367

From FANTOM5_SSTAR

Revision as of 13:49, 5 September 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C367_papillotubular_Macrophage_clear_pharyngeal_Renal_endometrial_tubular



Phase1 CAGE Peaks

Hg19::chr11:102401469..102401488,-p1@MMP7
Hg19::chr13:107026326..107026335,-p@chr13:107026326..107026335
-
Hg19::chr15:20093569..20093572,+p@chr15:20093569..20093572
+
Hg19::chr17:70636802..70636818,+p@chr17:70636802..70636818
+
Hg19::chr19:15923954..15923958,-p@chr19:15923954..15923958
-
Hg19::chr19:49522727..49522759,-p@chr19:49522727..49522759
-
Hg19::chr19:49545646..49545652,+p@chr19:49545646..49545652
+
Hg19::chr19:49545660..49545673,+p@chr19:49545660..49545673
+
Hg19::chr19:49545674..49545685,+p@chr19:49545674..49545685
+
Hg19::chr19:49545691..49545692,+p@chr19:49545691..49545692
+
Hg19::chr19:49553696..49553725,-p@chr19:49553696..49553725
-
Hg19::chr19:49553788..49553818,-p@chr19:49553788..49553818
-
Hg19::chr19:51472014..51472030,-p2@KLK6
Hg19::chr1:218785863..218785866,+p@chr1:218785863..218785866
+
Hg19::chr1:222159603..222159607,+p@chr1:222159603..222159607
+
Hg19::chr20:56283735..56283746,+p@chr20:56283735..56283746
+
Hg19::chr2:106016186..106016205,+p@chr2:106016186..106016205
+
Hg19::chr2:30440814..30440823,+p@chr2:30440814..30440823
+
Hg19::chr3:139035972..139036016,-p@chr3:139035972..139036016
-
Hg19::chr4:143369478..143369483,-p@chr4:143369478..143369483
-
Hg19::chr4:143395551..143395584,-p3@INPP4B
Hg19::chr4:143395591..143395600,-p16@INPP4B
Hg19::chr4:143395603..143395614,-p14@INPP4B
Hg19::chr6:1054763..1054800,-p@chr6:1054763..1054800
-
Hg19::chr7:98796685..98796688,-p@chr7:98796685..98796688
-
Hg19::chr7:98807901..98807908,-p@chr7:98807901..98807908
-
Hg19::chr7:98822527..98822533,+p@chr7:98822527..98822533
+
Hg19::chr7:99779265..99779276,+p15@STAG3
Hg19::chr9:132337683..132337714,+p1@ENST00000443993
p1@uc004bya.1
Hg19::chrX:46121582..46121588,-p@chrX:46121582..46121588
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0030574collagen catabolic process3.49113901529097e-05
GO:0044256protein digestion3.49113901529097e-05
GO:0044254multicellular organismal protein catabolic process3.49113901529097e-05
GO:0044266multicellular organismal macromolecule catabolic process3.49113901529097e-05
GO:0044259multicellular organismal macromolecule metabolic process3.49113901529097e-05
GO:0044268multicellular organismal protein metabolic process3.49113901529097e-05
GO:0044243multicellular organismal catabolic process3.49113901529097e-05
GO:0032963collagen metabolic process3.49113901529097e-05
GO:0044236multicellular organismal metabolic process3.738365344664e-05
GO:0007586digestion0.000592102168167378
GO:0004235matrilysin activity0.00137011228498335
GO:0016316phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity0.00251176160996224
GO:0004293tissue kallikrein activity0.00579560515052357
GO:0030163protein catabolic process0.00592419392120253
GO:0007130synaptonemal complex assembly0.00602716320831794
GO:0007129synapsis0.00659191867090141
GO:0043285biopolymer catabolic process0.00790864191242954
GO:0042577lipid phosphatase activity0.0100426108972329
GO:0000795synaptonemal complex0.0103064350029073
GO:0042982amyloid precursor protein metabolic process0.0105438101975185
GO:0042246tissue regeneration0.0111317409286778
GO:0009057macromolecule catabolic process0.0111317409286778
GO:0050435beta-amyloid metabolic process0.0111317409286778
GO:0031099regeneration0.0112949442082651
GO:0042552myelination0.015656790337173
GO:0004175endopeptidase activity0.0159698035176525
GO:0000794condensed nuclear chromosome0.0165549481747521
GO:0007272ensheathment of neurons0.0165549481747521
GO:0008366axon ensheathment0.0165549481747521
GO:0007127meiosis I0.0165549481747521
GO:0048589developmental growth0.0179596740625052
GO:0001508regulation of action potential0.0183529399737562
GO:0009056catabolic process0.0183529399737562
GO:0016540protein autoprocessing0.0203500138822008
GO:0016787hydrolase activity0.0207309052081313
GO:0000793condensed chromosome0.0217205866203829
GO:0004437inositol or phosphatidylinositol phosphatase activity0.0231604999529081
GO:0007059chromosome segregation0.0233402148347696
GO:0008233peptidase activity0.0246856409289252
GO:0044454nuclear chromosome part0.0246856409289252
GO:0051327M phase of meiotic cell cycle0.0246856409289252
GO:0007126meiosis0.0246856409289252
GO:0051321meiotic cell cycle0.0248082502336922
GO:0006508proteolysis0.0248798947491532
GO:0042445hormone metabolic process0.0293596090777808
GO:0016485protein processing0.0316086834367993
GO:0000228nuclear chromosome0.0316086834367993
GO:0042060wound healing0.0408964047267248
GO:0045595regulation of cell differentiation0.0440120927780186



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen
epithelial cell1.17e-20254
endo-epithelial cell1.31e-1543
endodermal cell1.04e-1459
kidney cell7.13e-0818
kidney epithelial cell7.13e-0818
epithelial cell of nephron3.75e-0716
epithelial cell of alimentary canal4.97e-0721
Uber Anatomy
Ontology termp-valuen
anatomical space4.98e-15104
immaterial anatomical entity8.78e-15126
organ2.69e-12511
trunk region element6.61e-12107
endoderm-derived structure2.28e-11169
endoderm2.28e-11169
presumptive endoderm2.28e-11169
mixed endoderm/mesoderm-derived structure1.50e-10130
anatomical cavity1.56e-1070
subdivision of trunk1.12e-09113
renal system1.16e-0945
subdivision of digestive tract1.38e-09129
endodermal part of digestive tract1.38e-09129
urinary system structure2.64e-0944
duct3.31e-0926
digestive system4.11e-09155
digestive tract4.11e-09155
primitive gut4.11e-09155
foregut4.86e-0998
multi-cellular organism3.29e-08659
body cavity precursor3.40e-0863
organism subdivision4.26e-08365
anatomical system5.18e-08625
cavitated compound organ6.03e-0832
respiratory system6.50e-0872
anatomical group6.83e-08626
mesonephros7.97e-0818
pronephros7.97e-0818
nephrogenic cord7.97e-0818
pronephric mesoderm7.97e-0818
rostral part of nephrogenic cord7.97e-0818
presumptive pronephric mesoderm7.97e-0818
excretory tube1.37e-0717
mesonephric epithelium1.37e-0717
mesonephric tubule1.37e-0717
nephric duct1.37e-0717
kidney epithelium1.37e-0717
renal duct1.37e-0717
mesonephric duct1.37e-0717
pronephric duct1.37e-0717
kidney2.07e-0727
kidney mesenchyme2.07e-0727
kidney rudiment2.07e-0727
kidney field2.07e-0727
intermediate mesoderm2.80e-0737
endo-epithelium3.19e-0782
nephron epithelium3.75e-0716
nephron3.75e-0716
uriniferous tubule3.75e-0716
metanephric mesenchyme3.75e-0716
nephrogenic mesenchyme3.75e-0716
urogenital ridge4.15e-0720
intraembryonic coelom7.82e-0721
Disease
Ontology termp-valuen
carcinoma6.10e-12106
adenocarcinoma2.40e-1025
cell type cancer2.05e-08143
squamous cell carcinoma3.69e-0714


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
ESR1#209966.15372065923090.000356321486410390.00356591220000141
NR3C1#290862.994604666234610.01309398003524260.0464480056008663



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

This analysis result is provided for C0 - C305 clusters.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C367&oldid=2132640"